Innovent Announces Oral Presentation at the ESMO Gastrointestinal Cancers Congress 2024 on Latest Clinical Data of Anti-CLDN18.2 ADC (IBI343) in Patients with Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

SAN FRANCISCO and SUZHOU, China, July 2, 2024 /PRNewswire/ — Innovent Biologics,…

Altos Biologics Files Approval of Aflibercept Biosimilar

DAEJEON, South Korea, July 2, 2024 /PRNewswire/ — Alteogen Inc. (KOSDAQ: 196170)…

Conform to trend of times, promote peace, development

BEIJING, July 2, 2024 /PRNewswire/ — A report from People’s Daily: From…

Eshallgo Inc Announces Pricing of Initial Public Offering

SHANGHAI, July 2, 2024 /PRNewswire/ — Eshallgo Inc ("Eshallgo" or the "Company")…

Block Earner Wins Excellence in Blockchain/Distributed Ledger Award at 2024 Finnies and Secures Recognition at WeMoney Awards

SYDNEY, July 2, 2024 /PRNewswire/ — Block Earner, a leading Australian cryptocurrency…

Bridgewest Perth Pharma gains strategic edge with noted Australian Executive John Van Der Wielen on Board

PERTH, Australia, July 2, 2024 /PRNewswire/ — Bridgewest Perth Pharma, global pharmaceutical holding company…

Lions Celebrate a Successful Year of Service at the 106th Lions International Convention

OAK BROOK, Ill., July 2, 2024 /PRNewswire/ — Lions International celebrated several…

Trading Technologies launches day-one connectivity to Abaxx Exchange

CHICAGO and SINGAPORE, July 2, 2024 /PRNewswire/ — Trading Technologies International, Inc.…